Introduction Executive Summary Peritoneal Cancer: Overview ● Causes ● Mechanism of Action ● Signs and Symptoms ● Diagnosis ● Disease Management Pipeline Therapeutics ● Comparative Analysis Therapeutic Assessment ● Assessment by Product Type ● Assessment by Stage and Product Type ● Assessment by Route of Administration ● Assessment by Stage and Route of Administration ● Assessment by Molecule Type ● Assessment by Stage and Molecule Type Peritoneal Cancer – DelveInsight’s Analytical Perspective In-depth Commercial Assessment ● Peritoneal Cancer companies’ collaborations, Licensing, Acquisition -Deal Value Trends Peritoneal Cancer Collaboration Deals ● Company-Company Collaborations (Licensing / Partnering) Analysis ● Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) ● Comparative Analysis Mirvetuximab Soravtansine: ImmunoGen ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I/II) ● Comparative Analysis Entinostat: Syndax Pharmaceuticals ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Preclinical Stage Products ● Comparative Analysis Drug Name: Company Name ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Inactive Products ● Comparative Analysis Peritoneal Cancer Key Companies Peritoneal Cancer Key Products Peritoneal Cancer- Unmet Needs Peritoneal Cancer- Market Drivers and Barriers Peritoneal Cancer- Future Perspectives and Conclusion Peritoneal Cancer Analyst Views Peritoneal Cancer Key Companies Appendix

Table 1 Total Products for Peritoneal Cancer Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Celsion • Hoffman-La-Roche • ImmunoGen • Syndax Pharmaceuticals • Immuno vaccine technologies, Inc. • Regeneron Pharmaceuticals • Aravive Biologics • K Group Beta • Lee’s pharmaceuticals • Y-mAbs Therapeutics